Pfizer Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $8.64B | $8.10B | $8.14B |
| Depreciation & Amortization | $4.76B | $5.09B | $5.20B |
| Depreciation | — | — | — |
| Amortization | $2.88B | $2.67B | $3.13B |
| Stock-Based Compensation | $349.0M | $384.0M | $437.0M |
| Net Cash from Operating Activities | $16.59B | $18.24B | $13.35B |
| Investing Activities | |||
| Capital Expenditures | $1.21B | $1.70B | $1.88B |
| Business Acquisitions | $43.12B | $1.18B | $464.0M |
| Net Cash from Investing Activities | $-31.27B | $-12.84B | $795.0M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | $0 | $500.0M | $9.99B |
| Net Cash from Financing Activities | $14.48B | $-6.56B | $-12.61B |
| Net Change in Cash | $-144.0M | $-1.28B | $1.58B |
| Free Cash Flow | $15.38B | $16.54B | $11.47B |